HETEROGENEITY OF THE 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE EFFICACY DUE TO VARIOUS UNDERLYING CONDITIONS OF CHRONIC PULMONARY DISEASE IN ELDERLY PATIENTS

被引:0
|
作者
Inoue, S. [1 ]
Kaneko, T. [2 ]
Morita, S. [2 ]
Natsumeda, Y. [3 ]
Mizushima, S. [1 ]
机构
[1] Yokohama City Univ, Grad Sch Med, Dept Epidemiol & Publ Hlth, Yokohama, Kanagawa 232, Japan
[2] Yokohama City Univ, Grad Sch Med, Dept Biostat & Epidemiol, Yokohama, Kanagawa 232, Japan
[3] Yokohama City Univ, Grad Sch Med, Lab Clin Res, Yokohama, Kanagawa 232, Japan
关键词
D O I
10.1136/jech.2011.142976d.71
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
引用
收藏
页码:A115 / A115
页数:1
相关论文
共 50 条
  • [1] Heterogeneity of the efficacy of the 23-valent pneumococcal polysaccharide vaccine caused by various underlying conditions of chronic pulmonary disease in older patients: prospective cohort study
    Inoue, Satoshi
    Watanuki, Yuji
    Kaneko, Tetsuji
    Sato, Takashi
    Miyazawa, Naoki
    Kaneko, Takeshi
    Ishigatsubo, Yoshiaki
    Morita, Satoshi
    Natsumeda, Yutaka
    Mizushima, Shunsaku
    BMJ OPEN, 2011, 1 (01):
  • [2] Effectiveness of 23-valent pneumococcal polysaccharide vaccine on diabetic elderly
    Kuo, Chia-Sheng
    Lu, Chia-Wen
    Chang, Yu-Kang
    Yang, Kuen-Cheh
    Hung, Shou-Hung
    Yang, Ming-Ching
    Chang, Hao-Hsiang
    Huang, Chi-Ting
    Hsu, Chih-Cheng
    Huang, Kuo-Chin
    MEDICINE, 2016, 95 (26)
  • [3] Immunogenicity of a 23-valent pneumococcal polysaccharide vaccine in Brazilian elderly
    Simonsen, V
    Brandao, AP
    Brandileone, MCC
    Yara, TI
    Di Fabio, JL
    Lopes, MH
    Jacob, W
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2005, 38 (02) : 251 - 260
  • [4] Immunogenicity and safety after the third vaccination with the 23-valent pneumococcal polysaccharide vaccine in elderly patients with chronic lung disease
    Ohshima, Nobuharu
    Akeda, Yukihiro
    Nagai, Hideaki
    Oishi, Kazunori
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2020, 16 (09) : 2285 - 2291
  • [5] Effectiveness of a 23-valent pneumococcal polysaccharide vaccine and a 13-valent pneumococcal conjugate vaccine among the elderly with chronic respiratory diseases
    Masuda, Toshihiro
    Akamatsu, Taisuke
    Nakatani, Eiji
    Tamura, Kanami
    Takahashi, Shingo
    Tanaka, Yuko
    Watanabe, Hirofumi
    Endo, Yoshinari
    Suzuki, Takahito
    Noguchi, Rie
    Saigusa, Mika
    Yamamoto, Akito
    Shishido, Yuichiro
    Akita, Takefumi
    Morita, Satoru
    Asada, Kazuhiro
    Shirai, Toshihiro
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [6] 23-valent pneumococcal polysaccharide vaccine against pneumococcal pneumonia
    Tanimoto, Tetsuya
    Kusumi, Eiji
    Hosoda, Kazutaka
    Hamaki, Tamae
    Takahashi, Kenzo
    LANCET INFECTIOUS DISEASES, 2017, 17 (07): : 692 - 693
  • [7] 23-valent pneumococcal polysaccharide vaccine against pneumococcal pneumonia
    Suzuki, Motoi
    Dhoubhadel, Bhim Gopal
    Katoh, Shungo
    Ariyoshi, Koya
    Morimoto, Konosuke
    LANCET INFECTIOUS DISEASES, 2017, 17 (08): : 803 - 804
  • [8] CLINICAL EFFICACY OF 23-VALENT POLYSACCHARIDE PNEUMOCOCCAL VACCINE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
    Tarasova, G.
    Belov, B.
    Egorova, O.
    Reshetnyak, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1369 - 1370
  • [9] 23-valent pneumococcal polysaccharide vaccine and the risk of renal progression in older patients with chronic kidney disease
    Chang, Po-Ya
    Lin, Chun-Ji
    Chen, Hao-Cheng
    Fan, Hueng-Chuen
    Kuo, Hsuchung
    PREVENTIVE MEDICINE, 2023, 177
  • [10] No preventive effects of 23-valent pneumococcal polysaccharide vaccine in patients with chronic renal failure
    Hsieh, Meng-Jer
    Yu, Chun-Chen
    Hu, Han-Chung
    Thai, Ying-Huang
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48